Published by Eli Lilly in December 2025, the results showed: Average weight loss of 28.7% at the 12mg dose over 68 weeks comparable to TRIUMPH-1 at the same dose Significant reductions in WOMAC pain scores a validated measure of knee pain and function More than 1 in 8 patients on retatrutide were completely free of knee pain by the end of the trial compared with less than 1 in 25 on placebo Significant improvements in physical function, stair climbing, and walking distance This matters clinically because knee osteoarthritis and obesity are deeply intertwined each kilogram of body weight lost reduces knee joint load by approximately 4 kilograms during walking
Cysteine oxidation produces disulfide bonds, sulfenic acid, sulfinic acid, and ultimately sulfonic acid
These powerful compounds stimulate collagen production, enhance skin elasticity, and provide an impeccable glow
For a marathoner, failing to fuel properly means hitting the wall at 30km
However, urine electrolytes remain one of our strongest bedside tools to differentiate causes of AKI